Stock Market

INCOME STATEMENT

You can view the income statement for the last 5 years.

Sun Pharma Advanced Research Company Ltd.

May 21, 10:25 BSE 186.20 (+ 2.85 1.55%)

Volume167676

Prev. Close
183.35

Open Price
186.95

Today's Low / High

182.75 188.60

Bid. Price (Qty.)186.05 (10)

Offer Price (Qty.)
186.20 (1)

52 Wk Low / High

108.20 204.25

May 21, 10:14 NSE 187.00(+ 3.32 1.81%)

Volume1865377

Prev. Close
183.68

Open Price
185.00

Today's Low / High

182.62 188.59

Bid Price (Qty.)187.06 (100)

Offer Price (Qty.) 187.10 (495)

52 Wk Low / High

108.00 204.40

(₹ in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23
Months	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR
FaceValue	1.00	1.00	1.00	1.00


INCOME
Revenue From Operations [Net]	39.15	71.77	75.55	238.78
Other Operating Revenues	1840.02	0.00	0.00	0.00
Total Operating Revenues	1879.17	71.77	75.55	238.78

Other Income	10.95	1.79	29.47	10.88
Total Revenue	1890.12	73.56	105.01	249.66

EXPENSES
Cost Of Materials Consumed	23.60	23.12	28.13	22.11
Operating And Direct Expenses	0.00	173.05	253.81	281.41
Employee Benefit Expenses	118.03	153.58	141.84	107.00
Finance Costs	34.13	9.04	1.69	7.63
Depreciation And Amortisation Expenses	10.21	12.39	12.51	11.77
Other Expenses	138.78	45.15	53.87	42.31
Total Expenses	324.75	416.34	491.85	472.24

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	1565.37	-342.78	-386.83	-222.58

Exceptional Items	-12.36	0.00	0.00	0.00
Profit/Loss Before Tax	1553.01	-342.78	-386.83	-222.58

Tax Expenses-Continued Operations
Current Tax	-0.19	0.73	1.63	0.00
Deferred Tax	0.00	-1.01	-1.25	0.00
Total Tax Expenses	-0.19	-0.27	0.38	0.00
Profit/Loss After Tax And Before ExtraOrdinary Items	1553.20	-342.51	-387.21	-222.58

Profit/Loss From Continuing Operations	1553.20	-342.51	-387.21	-222.58

Profit/Loss For The Period	1553.20	-342.51	-387.21	-222.58
Consolidated Profit/Loss After MI And Associates	1553.20	-342.51	-387.21	-222.58

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	47.86	-10.55	-11.93	-7.82
Diluted EPS (Rs.)	47.86	-10.55	-11.93	-7.82

Particulars	Mar 26
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR
FaceValue	1.00

INCOME
Revenue From Operations [Net]	39.15
Other Operating Revenues	1840.02
Total Operating Revenues	1879.17
Other Income	10.95
Total Revenue	1890.12
EXPENSES
Cost Of Materials Consumed	23.60
Operating And Direct Expenses	0.00
Employee Benefit Expenses	118.03
Finance Costs	34.13
Depreciation And Amortisation Expenses	10.21
Other Expenses	138.78
Total Expenses	324.75
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	1565.37
Exceptional Items	-12.36
Profit/Loss Before Tax	1553.01
Tax Expenses-Continued Operations
Current Tax	-0.19
Deferred Tax	0.00
Total Tax Expenses	-0.19
Profit/Loss After Tax And Before ExtraOrdinary Items	1553.20
Profit/Loss From Continuing Operations	1553.20
Profit/Loss For The Period	1553.20
Consolidated Profit/Loss After MI And Associates	1553.20
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	47.86
Diluted EPS (Rs.)	47.86

Stock Market

INCOME STATEMENT

Sun Pharma Advanced Research Company Ltd.

Become a Authorised Person / Franchise

Market Information

Open An Account Online

IPO Online

Mutual Fund

Login

Registrar and Transfer Agent(RTA)

Services

Research

Chat

Call